Viewing Study NCT06634446



Ignite Creation Date: 2024-10-26 @ 3:42 PM
Last Modification Date: 2024-10-26 @ 3:42 PM
Study NCT ID: NCT06634446
Status: RECRUITING
Last Update Posted: None
First Post: 2024-10-03

Brief Title: Self-administered COgnitive Personalized Training in Early Psychosis
Sponsor: None
Organization: None

Study Overview

Official Title: Self-administered COgnitive Personalized Training in Early Psychosis a Randomized Controlled Trial in Adolescents and Young Adults to Assess Efficacy and Efficiency of an EHealth Application Providing Personalized Cognitive Training
Status: RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SCOPe
Brief Summary: The overall objective of SCOPe is to improve early intervention in psychosis by providing an innovative eHealth tool that will enable personalized cognitive training adapted to the individuals cognitive abilities

Cognitive remediation improves quality of life and functional outcome in patients with chronic psychosis It would even be more efficacious in the early phase of psychosis by tackling the negative impact of psychosis on education achievement and employment However cognitive dysfunctions are often overlooked in FEP and cognitive remediation is not always accessible New technologies can provide us with youth-friendly non-stigmatizing tools such as self administered training applications so that all first-line clinical settings or professionals and in fine all patients can have access wherever they live to personalized cognitive training focusing on impaired functions

Early psychosis can be associated with inflammation metabolic deficiency as well as early structural brain anomalies that reflect brain plasticity abilities and could influence the prognosis and response to cognitive training

Our background hypothesis is that promoting neuroplasticity by cognitive training could attenuate or reverse early cognitive deficits and improve the overall functional outcome in young patients experiencing FEP and that this effect is modulated by individual brain plasticity abilities
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None